Sultan’s Score: A New Way to Predict Treatment Success for Liver Cancer
Author Information
Author(s): Muacevic Alexander, Adler John R, Alharbi Sultan R
Primary Institution: King Saud University
Hypothesis
Can a new imaging-based scoring system accurately predict complete response to drug-eluting bead chemoembolization in patients with hepatocellular carcinoma?
Conclusion
The Sultan’s score effectively predicts complete response in patients with hepatocellular carcinoma after treatment.
Supporting Evidence
- 28 patients (68.3%) showed complete response after treatment.
- The Sultan’s score had a sensitivity of 78.6% and specificity of 76.9% for predicting complete response.
- Patients with higher Sultan’s scores were more likely to achieve complete response.
Takeaway
Doctors created a new score to help figure out which liver cancer patients will respond well to a specific treatment. The higher the score, the better the chance of success.
Methodology
Retrospective analysis of 41 patients with solitary hepatocellular carcinoma treated with drug-eluting TACE, collecting clinical data and outcomes.
Potential Biases
Selection bias may be present due to the retrospective design.
Limitations
The study is retrospective, includes only solitary HCC cases, is single-centered, has a small sample size, and lacks external validation.
Participant Demographics
Participants included 41 patients (28 men and 13 women) with a mean age of 68.29 years, primarily with hepatitis C as the etiology.
Statistical Information
P-Value
0.031
Confidence Interval
0.688-0.966
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website